Juvenile Idiopathic Arthritis (JIA) Registry

Part of paid clinical trials in Phoenix, Arizona.

Sponsor
AbbVie
Study ID
NCT00783510
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
2 Years - 17 Years
Healthy Volunteers
Not accepted

Interventions

  • adalimumab — BIOLOGICAL
    As prescribed by treating physician
  • Methotrexate — DRUG
    As prescribed by treating physician

Study Details

This is a global registry, to evaluate the long-term safety of Humira® in patients with moderate to severe polyarticular Juvenile Idiopathic Arthritis (JIA), that are treated as recommended in the Humira® product label. Patients treated with MTX will be considered a reference group. Patients will be followed in both the Humira® and Methotrexate (MTX) arms for 10 years from the enrollment date into one of the treatment arms.

Key Dates

Start date
Jul 11, 2008
Status verified
Jan 2025
Primary completion
Feb 1, 2024
Completion
Feb 1, 2024

Study Design

Enrollment
849 participants (actual)

Arms

  • Arm: HUMIRA® Treatment Arm
    For patients taking HUMIRA®
  • Arm: Methotrexate Treatment Arm
    For patients taking Methotrexate

Primary Outcome Measure

Incidence of Serious Adverse Events (SAEs) [ Time Frame: Up to 10 years ]

Locations (32)

FacilityCityStateZIPSite coordinators
AZ Arthritis and Rheumotology Research, PLLC /ID# 21023PhoenixArizona85032-9306-
Catalina Pointe Clinical Research /ID# 40227TucsonArizona85704-
Arkansas Children's Hospital /ID# 23505Little RockArkansas72202-
Children's Hospital Los Angeles /ID# 24386Los AngelesCalifornia90027-
Children's National Medical Center /ID# 23506Washington D.C.District of Columbia20010-2916-
Duplicate_Arthritis Associates South FL /ID# 17001Delray BeachFlorida33484-
Ann & Robert H Lurie Children's Hospital of Chicago /ID# 20966ChicagoIllinois60611-
The University of Chicago Medical Center /ID# 21981ChicagoIllinois60637-1443-
Methodist Medical Group Rheum /ID# 46343PeoriaIllinois61602-
Indiana University /ID# 11421IndianapolisIndiana46202-
University of Louisville /ID# 23507LouisvilleKentucky40202-
Arthritis Care Spec. of MD /ID# 21961Ellicott CityMaryland21042-
Tufts Medical Center /ID# 21965BostonMassachusetts02111-1552-
Creighton Univ Med Ctr /ID# 11423OmahaNebraska68131-
St. Barnabas Ambulatory Care /ID# 21025West OrangeNew Jersey07052-
North Shore University Hospital /ID# 21022New Hyde ParkNew York11040-
University of Rochester Medical Center /ID# 20967RochesterNew York14642-
New York Medical College /ID# 21964ValhallaNew York10595-
Duke Cancer Center /ID# 22904DurhamNorth Carolina27710-3000-
Bone Spine Sports/Medctr One /ID# 21962BismarckNorth Dakota58501-
Akron Children's Hospital /ID# 22907AkronOhio44308-
University of Cincinnati /ID# 14101CincinnatiOhio45267-0585-
Nationwide Children's Hospital /ID# 21963ColumbusOhio43205-2664-
Legacy Emanuel Medical Center /ID# 14102PortlandOregon97227-
St. Christopher's Hospital /ID# 24385PhiladelphiaPennsylvania19134-
Arthritis Associates of Kingsport /ID# 44462KingsportTennessee37660-
Dr. Ramesh Gupta /ID# 45342MemphisTennessee38119-
Scott & White Health Care /ID# 36762Round RockTexas78665-
University of Utah /ID# 21041Salt Lake CityUtah84112-5500-
Children's Speciality Center /ID# 11503BurlingtonVermont05401-
Seattle Children's Hospital /ID# 20968SeattleWashington98105-
Children's Hospital Wisconsin - Milwaukee Campus /ID# 40226MilwaukeeWisconsin53226-

Find similar trials in Phoenix, AZ

Related Studies